119-hr-8205Passed Senate

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Sponsored by Quigley, Mike (Democrat-IL-5) · House · Introduced Apr 6, 2026

AI-assisted analysis: Summaries and rider analysis are generated using AI and reviewed for accuracy. This tool is for informational purposes only. Always verify with official sources before making decisions.Learn about our methodology.

Plain-English Summary (AI-assisted)

This bill extends the Accelerating Access to Critical Therapies for ALS Act through fiscal year 2031. The original act created expedited pathways for developing and approving treatments for ALS (amyotrophic lateral sclerosis), a fatal neurological disease.

HealthDepartment of Health and Human ServicesDrug therapyFood and Drug Administration (FDA)Government information and archivesHealth programs administration and fundingInternet, web applications, social mediaMedical researchNational Institutes of Health (NIH)Neurological disordersPublic-private cooperationResearch administration and funding

Legislative Status Timeline

Introduced

Apr 6, 2026

In Committee

Completed

Passed House

Completed

Passed Senate

Sep 28, 2026

Presidential Action

Pending

Sponsor

Q

Quigley, Mike

Independent · IL-5

Want to know when this bill's status changes?

Get notified about 119-hr-8205 and other IL legislation.